123 related articles for article (PubMed ID: 22584716)
1. Temozolomide in aggressive pituitary adenomas and carcinomas.
Ortiz LD; Syro LV; Scheithauer BW; Rotondo F; Uribe H; Fadul CE; Horvath E; Kovacs K
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):119-23. PubMed ID: 22584716
[TBL] [Abstract][Full Text] [Related]
2. Refractory nonfunctioning pituitary adenomas.
Kolitz T; Greenman Y
Pituitary; 2023 Jun; 26(3):278-280. PubMed ID: 36786972
[TBL] [Abstract][Full Text] [Related]
3. Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide.
DE Alcubierre D; Carretti AL; Ducray F; Jouanneau E; Raverot G; Ilie MD
Minerva Endocrinol (Torino); 2024 Jan; ():. PubMed ID: 38240681
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide for aggressive pituitary tumors:-A literature review.
Hui-Zheng H; Lei L
Asian J Surg; 2024 Feb; 47(2):1300-1301. PubMed ID: 38030489
[No Abstract] [Full Text] [Related]
5. A case of multiple radiation-induced gliomas 24 years after radiation therapy against pituitary adenoma.
Kato A; Nagashima G
Clin Case Rep; 2016 Apr; 4(4):356-60. PubMed ID: 27099727
[TBL] [Abstract][Full Text] [Related]
6. The role of temozolomide in the treatment of aggressive pituitary tumors.
Liu JK; Patel J; Eloy JA
J Clin Neurosci; 2015 Jun; 22(6):923-9. PubMed ID: 25772801
[TBL] [Abstract][Full Text] [Related]
7. Aggressive prolactinoma (Review).
Valea A; Sandru F; Petca A; Dumitrascu MC; Carsote M; Petca RC; Ghemigian A
Exp Ther Med; 2022 Jan; 23(1):74. PubMed ID: 34934445
[TBL] [Abstract][Full Text] [Related]
8. Pituitary carcinoma: Two case reports and review of literature.
Xu L; Khaddour K; Chen J; Rich KM; Perrin RJ; Campian JL
World J Clin Oncol; 2020 Feb; 11(2):91-102. PubMed ID: 32133278
[TBL] [Abstract][Full Text] [Related]
9. Pituitary-Directed Therapies for Cushing's Disease.
Langlois F; Chu J; Fleseriu M
Front Endocrinol (Lausanne); 2018; 9():164. PubMed ID: 29765354
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.
Perry A; Graffeo CS; Marcellino C; Pollock BE; Wetjen NM; Meyer FB
J Neurol Surg B Skull Base; 2018 Feb; 79(1):91-114. PubMed ID: 29404245
[No Abstract] [Full Text] [Related]
11. Pituitary Carcinoma in a Patient with an SDHB Mutation.
Tufton N; Roncaroli F; Hadjidemetriou I; Dang MN; Dénes J; Guasti L; Thom M; Powell M; Baldeweg SE; Fersht N; Korbonits M
Endocr Pathol; 2017 Dec; 28(4):320-325. PubMed ID: 28284009
[TBL] [Abstract][Full Text] [Related]
12. How effective is temozolomide for treating pituitary tumours and when should it be used?
Halevy C; Whitelaw BC
Pituitary; 2017 Apr; 20(2):261-266. PubMed ID: 27581836
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.
Losa M; Bogazzi F; Cannavo S; Ceccato F; Curtò L; De Marinis L; Iacovazzo D; Lombardi G; Mantovani G; Mazza E; Minniti G; Nizzoli M; Reni M; Scaroni C
J Neurooncol; 2016 Feb; 126(3):519-25. PubMed ID: 26614517
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide-Induced Shrinkage of Invasive Pituitary Adenoma in Patient with Nelson's Syndrome: A Case Report and Review of the Literature.
Kurowska M; Nowakowski A; Zieliński G; Malicka J; Tarach JS; Maksymowicz M; Denew P
Case Rep Endocrinol; 2015; 2015():623092. PubMed ID: 26221547
[TBL] [Abstract][Full Text] [Related]
15. Treatment of invasive silent somatotroph pituitary adenoma with temozolomide. Report of a case and review of the literature.
Ghazi AA; Rotondo F; Kovacs K; Amirbaigloo A; Syro LV; Fathalla H; Di Ieva A; Cusimano MD
Endocr Pathol; 2015 May; 26(2):135-9. PubMed ID: 25716461
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pituitary carcinomas and atypical pituitary adenomas: a review.
Hirohata T; Ishii Y; Matsuno A
Neurol Med Chir (Tokyo); 2014; 54(12):966-73. PubMed ID: 25446382
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy of Cushing's syndrome.
Eckstein N; Haas B; Hass MD; Pfeifer V
Orphanet J Rare Dis; 2014 Aug; 9():122. PubMed ID: 25091295
[TBL] [Abstract][Full Text] [Related]
18. Aggressive pituitary adenomas--diagnosis and emerging treatments.
Di Ieva A; Rotondo F; Syro LV; Cusimano MD; Kovacs K
Nat Rev Endocrinol; 2014 Jul; 10(7):423-35. PubMed ID: 24821329
[TBL] [Abstract][Full Text] [Related]
19. Invasive adenoma and pituitary carcinoma: a SEER database analysis.
Hansen TM; Batra S; Lim M; Gallia GL; Burger PC; Salvatori R; Wand G; Quinones-Hinojosa A; Kleinberg L; Redmond KJ
Neurosurg Rev; 2014 Apr; 37(2):279-85; discussion 285-6. PubMed ID: 24526366
[TBL] [Abstract][Full Text] [Related]
20. Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation.
Maclean J; Aldridge M; Bomanji J; Short S; Fersht N
Pituitary; 2014 Dec; 17(6):530-8. PubMed ID: 24323313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
